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Junction Adhesion Molecule
Is a Receptor for Reovirus
segregate with the viral S1 gene, which encodes the
viral attachment protein, s1.
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Turner et al., 1992; Nibert et al., 1995) and modulates
CNS tropism in mice (Spriggs et al., 1983; Kaye et al.,
1986). These data have led to a model in which the
Summary interaction of the s1 head with distinct T1 and T3 recep-
tors determines route of spread, tissue tropism, and
Virus attachment to cells plays an essential role in viral resultant disease.
tropism and disease. Reovirus serotypes 1 and 3 differ Despite the foundational nature of these observations
in the capacity to target distinct cell types in the murine for our understanding of mammalian reovirus tropism
nervous system and in the efficiency to induce apopto- and pathogenesis, cellular receptors for the s1 head
sis. The binding of viral attachment protein s1 to un- domain have not been identified. Previous attempts to
identified receptors controls these phenotypes. We identify reovirus receptors have yielded promising can-
used expression cloning to identify junction adhesion didates (Noseworthy et al., 1983; Co et al., 1985); how-
molecule (JAM), an integral tight junction protein, as ever, the molecular cloning of cellular molecules confer-
a reovirus receptor. JAM binds directly to s1 and per- ring reovirus infection has not been reported. These
mits reovirus infection of nonpermissive cells. Ligation earlier studies were perhaps confounded by the use of
of JAM is required for reovirus-induced activation of SA-binding T3 reovirus as an affinity ligand, an approach
NF-kB and apoptosis. Thus, reovirus interaction with that might isolate highly sialyllated molecules regardless
cell-surface receptors is a critical determinant of both of their affinity for the s1 head (Choi et al., 1990).
cell-type specific tropism and virus-induced intracel- In addition to targeting viral replication to neurons, T3
lular signaling events that culminate in cell death. s1 triggers signaling events that lead to apoptosis of
infected cells. Reovirus infection induces apoptosis in
cultured cells (Tyler et al., 1995) and in vivo (Oberhaus
Introduction et al., 1997). T3 reovirus strains induce apoptosis more
efficiently than T1 strains, which is a phenotype regu-
Mammalian reoviruses were one of the first animal virus lated by the s1-encoding S1 gene (Tyler et al., 1995).
systems to permit a molecular genetic approach to anal- Reovirus infection also activates nuclear factor kappa
ysis of viral replication and pathogenesis. Reoviruses B (NF-kB) (Connolly et al., 2000), an evolutionarily con-
infect most children and can cause mild gastrointestinal served transcription factor that plays critical roles in
or respiratory illnesses (Tyler and Fields, 1996). Studies determining cell fate and regulating immune responses
of reovirus disease in mice established the importance (Neurath et al., 1998; Barkett and Gilmore, 1999). Activa-
of the viral attachment step as a critical determinant of tion of NF-kB by reovirus is required for apoptosis induc-
disease outcome in the host (Sharpe and Fields, 1985). tion, since apoptosis elicited by reovirus is significantly
Following oral inoculation into newborn mice, serotype reduced in cells expressing a transdominant inhibitor of
1 (T1) reoviruses spread hematogenously to the CNS NF-kB and in cells deficient in the expression of NF-kB
and replicate in ependymal cells, resulting in hydroceph- subunits p50 and p65 (Connolly et al., 2000). Together,
alus. In contrast, serotype 3 (T3) reoviruses spread neu- these findings suggest that the binding of T3 s1 to its
rally to the CNS, where they replicate in neurons causing receptors results in nuclear translocation of NF-kB and
lethal encephalitis (Weiner et al., 1980). Since reovirus expression of cellular genes required for activation of
contains a segmented genome, pathogenic phenotypes the apoptotic machinery.
can be ascribed to specific viral genes by screening To permit dissection of the mechanism by which s1–
reassortant viruses. Using this approach, it was deter- receptor interactions control reovirus tropism, apopto-
mined that the mode of spread in the host (Tyler et al., sis, and disease, we employed an expression-cloning
1986) and cell tropism in the CNS (Weiner et al., 1980) approach to identify the cellular receptor for the T3 s1
head domain. Screening of a human neuronal-precursor
cell cDNA library identified junction adhesion moleculek To whom correspondence should be addressed (e-mail: terry.
(JAM) as a reovirus receptor. JAM is a member of thedermody@mcmail.vanderbilt.edu).
# These authors contributed equally to this work. immunoglobulin superfamily (IgSF) involved in regula-
Cell
442
tion of tight junction (TJ) formation (Liu et al., 2000) and
leukocyte transmigration across endothelium (Martin-
Padura et al., 1998; Del Maschio et al., 1999). We demon-
strate that non-SA-binding T1 and T3 reovirus strains
are completely dependent on s1–JAM interactions to
establish infection. However, SA-binding strains are also
capable of infection by a JAM-independent, SA-medi-
ated pathway. NF-kB activation and apoptosis induced
by SA-binding T3 reovirus requires interaction between
T3 s1 and JAM, indicating that reovirus infection is not
sufficient to trigger apoptosis in the absence of JAM-
induced signaling. These data indicate that JAM serves
as a serotype-independent reovirus receptor capable of
mediating virus attachment, infection, and intracellular
signaling. Furthermore, by linking an integral TJ protein
to the NF-kB signaling pathway, our results highlight
a potential role for the TJ in regulating tissue-specific
inflammatory responses to viral infection.
Results
Figure 1. Identification of JAM as a Reovirus Receptor by Expres-Expression Cloning of hJAM, a Reovirus Receptor
sion CloningTo facilitate the identification of reovirus receptors based
(A) COS-7 cells were transfected with an NT2-cell cDNA libraryon the capacity to bind directly to the s1 head, non-SA-
and incubated with FITC-labeled T3SA2 virions. The 0.5% mostbinding T3 reovirus strain T3SA2 was used as an affinity
fluorescent cells were collected by FACS for plasmid rescue. Per-ligand (Barton et al., 2001) in a FACS-based expression-
cent cells binding virus in (B), (C), and (D) is expressed relative to
cloning approach (Aruffo and Seed, 1987). NT2 cells are cells transfected with NT2-cell cDNA library.
human neuronal-precursor cells that support T3 reovirus (B) Virus binding to cells transfected with plasmid obtained from a
infection (data not shown). An NT2 cDNA library was positive pool of 50 bacterial transformants (pool 8) following four
rounds of FACS enrichment.selectively enriched for cDNAs that confer binding of
(C) Virus binding to cells transfected with plasmid from positivefluoresceinated T3SA2 (FITC-T3SA2) virions to trans-
subpool 8-10, containing 5 bacterial transformants.fected COS-7 cells (Figures 1A–1D). After four rounds
(D) Virus binding to cells transfected with plasmid from hJAM-
of FACS enrichment and sib selection, four clones were encoding clone 8-10-2.
identified that conferred FITC-T3SA2 binding to greater
than 20% of transfected cells, which was equivalent to
the transfection efficiency in these experiments (Figure Fab fragments (Fabs) of s1-specific mAb 9BG5 (Burstin
1D). All four clones encoded hJAM (Liu et al., 2000), et al., 1982), which binds the T3 s1 head domain
which suggests that hJAM is a reovirus receptor. (Chappell et al., 2000), and each of four anti-hJAM mAbs
tested (Figure 2E). Control antibodies directed against
CD47 (mAb C5/D5) (Parkos et al., 1996) and the humanAntibodies Directed against hJAM Inhibit Reovirus
Infection by Abrogation of Virus Binding coxsackievirus and adenovirus receptor (hCAR) (J. Ber-
gelson, personal communication), had no effect on reo-To test the hypothesis that hJAM is a reovirus receptor,
we determined whether anti-hJAM monoclonal antibod- virus binding. Anti-hJAM mAb J10.4 inhibited T3SA2
binding to NT2 cells in a dose-dependent manner, withies (mAbs) could inhibit reovirus infection (Figure 2). For
these experiments, we used NT2 cells (Figure 2A), HeLa a minimal inhibitory concentration between 0.2 and 0.02
mg/ml (Figure 2E). Anti-hJAM mAb J10.4 also signifi-cells (Figure 2B), and Caco-2 cells (Figures 2C and 2D),
an intestinal epithelial cell line. Cells were treated with cantly inhibited binding of strain T3SA1 to NT2 cells
(Figure 2E); however, residual virus binding above back-anti-hJAM mAbs 7G2C9 or J10.4 (Liu et al., 2000) prior
to infection with T3SA2 . In the absence of anti-hJAM ground remained. Preincubation of T3SA1 with sialyllac-
tose (SLL) to inhibit binding to cell-surface SA (Bartonantibodies, T3SA2 grew efficiently in all three cell types.
In contrast, anti-hJAM mAbs dramatically inhibited et al., 2001) abolished T3SA1 binding to NT2 cells
treated with mAb J10.4 (Figure 2E). These results indi-T3SA2 growth, resulting in 10- to 100-fold reduction
in viral yield. In each case, decreased viral yield was cate that T3SA2 binds to hJAM, while T3SA1 binds to
both hJAM and SA on NT2 cells. Together, these resultsmediated by reduction in the number of infected cells
(Figure 2D and data not shown). These results indicate strongly suggest that reovirus binding and infection are
dependent on the availability of hJAM to serve as athat hJAM binding is critical for reovirus infection of
multiple cell types, including cells of intestinal and neural reovirus receptor.
lineages.
To determine whether anti-hJAM mAbs inhibit reovi- Transient Transfection of hJAM Renders Murine
Erythroleukemia (MEL) Cells Permissive forrus infection at the viral attachment step, we assessed
the capacity of these mAbs to block binding of radiola- Infection by T1 and T3 Reovirus Strains
If hJAM functions as a bona fide reovirus receptor, thenbeled T3SA2 and an SA-binding T3 strain T3SA1 (Barton
et al., 2001) to NT2 cells (Figure 2E). Binding of T3SA2 transfection of reovirus-resistant cells with hJAM should
permit reovirus infection. To test this prediction, we usedto NT2 cells was inhibited by unlabeled competitor virus,
Junction Adhesion Molecule Is a Reovirus Receptor
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Figure 2. JAM Is Required for Reovirus Bind-
ing and Infection of NT2 Cells, HeLa Cells,
and Caco-2 Cells
(A–C) Effect of anti-hJAM mAbs on T3SA2
growth in cultured cells. NT2 cells (A), HeLa
Cells (B), or Caco-2 cells (C) were incubated
in the presence or absence of 20 mg/ml CD47-
specific mAb C5/D5 or 1 mg/ml of hJAM-spe-
cific mAbs 7G2C9 or J10.4 prior to adsorption
with T3SA2 at an MOI of 1 PFU/cell. Antibod-
ies and inocula were removed, cells were in-
cubated for the times shown, and progeny
virions were quantitated by plaque assay.
Shown are mean viral titers for three experi-
ments. Error bars indicate standard devia-
tions.
(D) Effect of anti-hJAM mAbs on T3SA2 infec-
tion of Caco-2 cells. Caco-2 cells were
treated with CD47-specific mAb C5/D5 (20
mg/ml) or hJAM-specific mAbs (5 mg/ml) prior
to infection with T3SA2 at an MOI of 100 PFU/
cell. After incubation for 24 hr, infected cells
were visualized by indirect immunofluores-
cence.
(E) Effect of anti-hJAM mAbs on binding of
T3SA2 and T3SA1 to NT2 cells. Cells were
untreated as a control, incubated with unla-
beled virus as competitor, or pretreated with
the mAbs shown prior to adsorption with ra-
dioiodinated virions of T3SA2 or T3SA1 . Viri-
ons also were untreated or pretreated with 5
mM SLL or 9BG5 Fabs (50 mg/ml). Antibodies
were used at either 20 mg/ml or the concen-
trations shown. Cell-associated virus was
captured by vacuum filtration and quantitated
by liquid scintillation. Error bars indicate the
range of values from duplicate experiments.
MEL cells, which are resistant to infection by T1 strains To test the hypothesis that JAM is a receptor for both
T1 and T3 reovirus, we assessed the capacity of anti-and non-SA-binding T3 strains, but support infection by
SA-binding T3 strains (Rubin et al., 1992; Barton et al., hJAM mAbs to block the binding of T1L and T3D to NT2
cells (Figures 3C and 3D). T1L binding to NT2 cells was2001). MEL cells were transiently transfected with empty
vector or hJAM-encoding plasmid and infected with abolished by either Fabs of mAb 5C6, which is specific
for the T1 s1 head domain (Chappell et al., 2000), or anti-T3SA2 or T3SA1 (Figure 3A). As expected, T3SA1 but
not T3SA2 grew efficiently in vector-transfected cells. hJAM mAb J10.4 (Figure 3C). T3D bound much more effi-
ciently than T1L to NT2 cells (Figure 3D), but .60% ofIn contrast, yields of T3SA2 were 10-fold greater in cells
transfected with hJAM than in vector-transfected cells. T3D binding was inhibited by either 9BG5 Fabs or mAb
J10.4 (Figure 3D). Significant binding of T3D remainedThis result indicates that expression of hJAM in MEL
cells rescues infection of non-SA-binding reovirus. even in the presence of anti-hJAM mAbs, consistent
with the fact that T3D s1 also can bind SA (Chappell etWe also tested the effect of transient hJAM expression
on growth of prototype reovirus strains T1 Lang (T1L) al., 2000). These results indicate that prototype T1 and T3
reovirus strains recognize hJAM as a receptor on a humanand T3 Dearing (T3D) in MEL cells (Figure 3B). As antici-
pated, SA-binding strain T3D grew efficiently in vector- neuronal-precursor cell line. However, in addition to recog-
nition of hJAM, strain T3D binds an additional NT2 mole-and hJAM-transfected MEL cells. Surprisingly, although
T1L did not infect vector-transfected MEL cells, it grew cule that is likely to be SA (Figure 2E).
efficiently in hJAM-transfected MEL cells. Given that
serotype-dependent differences in reovirus tropism and Transient Transfection of hJAM or Murine JAM
(mJAM) Renders Chicken Embryo Fibroblastpathogenesis are thought to be determined by differ-
ences in receptor utilization (Sharpe and Fields, 1985), (CEF) Cells Permissive for Infection by T1
and T3 Reovirus Strainsthis result was unexpected and suggests that T1 and T3
reovirus strains utilize JAM as a serotype-independent Since MEL cells support growth of some reovirus
strains, we thought it possible that transfection of thisreceptor.
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particles bind cell-surface receptors but do not require
endocytic proteolysis for infection (Baer and Dermody,
1997). ISVPs were used in this experiment since we
reasoned that CEF cells might not express endosomal
proteases required for mammalian reovirus disassem-
bly. This was found to be the case, since neither control
nor JAM-expressing CEF cells supported infection with
virions of any reovirus strain (data not shown). However,
ISVPs of T1L, T3SA2 , and T3SA1 were capable of in-
fecting CEF cells transfected with hJAM or mJAM but
not hCAR (Figure 4). These results indicate that the block
to reovirus infection in avian cells is rescued by expres-
sion of hJAM or mJAM, providing strong evidence that
JAM functions as a serotype-independent reovirus re-
ceptor in both human and murine hosts. Furthermore,
these findings suggest that the attachment and disas-
sembly steps of the reovirus life cycle serve as key
determinants of the host-range restriction exhibited by
diverse classes of vertebrates.
Figure 3. JAM Rescues Infectivity of T1 and T3 Reovirus Strains
(A and B) Effect of JAM expression on growth of T1 and T3 reovirus
strains in MEL cells. MEL cells were transiently transfected with hJAM Binds Directly to the Reovirus s1 Head
control vector (pBK) or hJAM clones 1-4-3 and 1-4-5. Transfected Domain with High Affinity
cells were adsorbed with T3SA2 , T3SA1 , T1L, or T3D at an MOI of
To exclude the possibility that hJAM indirectly enhances1 PFU/cell and incubated for either 24 (A) or 48 (B) hr. Viral titers
reovirus infection at a post-attachment step, we usedwere determined by plaque assay. Shown are mean viral yields (titer
surface plasmon resonance (SPR) to determine whetherat 24 or 48 hr divided by titer at 0 hr) for three experiments. Error
bars indicate standard deviations. reovirus particles and s1 protein bind directly to hJAM
(C and D) Effect of anti-hJAM mAbs on binding of T1 and T3 reovirus (Karlsson and Falt, 1997) (Figure 5). For these experi-
strains to NT2 cells. NT2 cells were incubated with CD47-specific ments, we generated a fusion protein consisting of the
mAb C5/D5 (20 mg/ml) or hJAM-specific mAb J10.4 (2 mg/ml) prior
rabbit Ig Fc domain linked to the extracellular domainto adsorption with radioiodinated T1L (C) or T3D (D). Virions were
of hJAM (Fc-hJAM). A fusion of the rabbit Fc with hCARpretreated with the inhibitors shown.
(Fc-hCAR) was used as a control for nonspecific interac-
tions (Bergelson et al., 1997). Fc-hJAM and Fc-hCAR
were conjugated to SPR sensor chips, and purified viri-cell type with hJAM might upregulate an endogenous
receptor. Therefore, we tested the capacity of cDNAs ons of T3SA2 , T3SA1 , T1L, or T3D were injected across
the Fc-hJAM and Fc-hCAR flow cells (Figure 5A). Virionsencoding either hJAM or mJAM to confer reovirus infec-
tion to CEF cells, which do not support reovirus infection of all four strains displayed a time-dependent increase in
binding to Fc-hJAM, and this binding was stable during(Figure 4). CEF cells were transiently transfected with
hCAR-, hJAM-, or mJAM-encoding plasmids and in- buffer wash. Virions did not bind to Fc-hCAR, and prein-
jection of anti-hJAM mAbs blocked virus binding tofected with virions or infectious subvirion particles
(ISVPs) of T1L, T3SA2 , or T3SA1 . ISVPs are reovirus hJAM, indicating that binding was specific for the hJAM
extracellular domain (Figure 5A and data not shown).disassembly intermediates generated in vivo in the in-
testinal lumen or in endocytic vesicles and in vitro by To determine whether reovirus binding to hJAM is
mediated by s1, T3SA1 virions were incubated withprotease treatment (Baer and Dermody, 1997). These
Figure 4. Transfection of CEF Cells with
hJAM or mJAM Enables Infection by T1 and
T3 Reovirus
CEF cells were transiently transfected with
plasmid encoding hCAR, hJAM, or mJAM.
Transfected CEF cells were adsorbed with
ISVPs of T1L, T3SA2 , or T3SA1 at an MOI of
10 PFU/cell. Reovirus antigen was detected
by indirect immunofluorescence 20 hr post-
infection. Parallel transfections were per-
formed using pEGFP-N1 as an indicator of
transfection efficiency.
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specific inhibitors of either the s1 SA binding domain
(SLL) or the s1 head RBD (9BG5 Fabs) (Figure 5B). Bind-
ing of T3SA1 to Fc-hJAM was not inhibited by SLL,
indicating that binding to SA on hJAM glycosylation
chains is not required for this interaction. In contrast,
preincubation of T3SA1 virions with 9BG5 Fabs, but not
control 5C6 Fabs, substantially reduced T3SA1 binding
to Fc-hJAM, suggesting that this binding is mediated
by the s1 head.
To investigate whether hJAM interacts directly with
s1, we tested the capacity of recombinant s1 to bind
Fc-hJAM (Figure 5C). Purified T3D s1 (Chappell et al.,
2000) bound specifically, saturably, and reversibly to Fc-
hJAM. Kinetic analysis of the s1-Fc-hJAM interaction
assuming 1:1 stoichiometry indicated a KD of approxi-
mately 9 3 1028 M (Karlsson and Falt, 1997). SLL had
no effect on the binding of s1 to Fc-hJAM, confirming
that this interaction does not require SA (data not
shown).
To confirm that the s1 head mediates binding to
hJAM, a proteolytically derived fragment of s1 con-
taining only the s1 head was injected over the Fc-hJAM
surface (Figure 5C). The s1 head domain bound specifi-
cally to Fc-hJAM with a KD of 6 3 1028 M, which approxi-
mates that of full-length s1. These results indicate that
the head domain of reovirus attachment protein s1 binds
with high affinity directly to the extracellular domain of
hJAM.
Figure 5. Quantitation of s1 Binding Affinity to hJAM Using Surface
Reovirus–JAM Interactions Are Required Plasmon Resonance
for Activation of NF-kB and Induction (A) T1 and T3 reovirus strains interact directly with hJAM. Virions
of Apoptosis during Reovirus Infection of T3SA2 , T3SA1 , T1L, or T3D were injected over biosensor surfaces
Reovirus infection of cultured cells leads to NF-kB acti- coated with either Fc-hJAM or Fc-hCAR fusion proteins. Binding in
response units was measured over time.vation, which is required for reovirus-induced apoptosis
(B) T3SA1 binding to hJAM is not dependent on SA. Binding of(Connolly et al., 2000). To determine whether engage-
T3SA1 to Fc-hJAM and Fc-hCAR on a biosensor was assessed inment of JAM by s1 triggers these cellular responses,
the presence of SLL, lactose (control), or Fabs of 9BG5 or 5C6
we tested the capacity of T3SA1 to replicate, activate (control).
NF-kB, and induce apoptosis in the presence of anti- (C) The s1 head domain binds to hJAM. Purified T3D s1 or s1 head
hJAM mAbs. The presence of residual binding of T3SA1 domain were injected over a biosensor coated with Fc-hJAM or Fc-
hCAR. Calculated affinities for binding to Fc-hJAM, expressed asand T3D to NT2 cells preincubated with anti-hJAM mAbs
apparent KD, are shown.(Figures 2E and 3D) suggested that reovirus can bind
SA in the absence of s1–JAM interactions. To assess
whether binding to SA alone could mediate reovirus HeLa cells (Connolly et al., 2000), we predicted that
blockade of NF-kB activation by mAb J10.4 would corre-entry, HeLa cells were incubated in the presence or
absence of anti-hJAM mAb J10.4 prior to adsorption late with decreased apoptosis. In untreated cells, T3SA1
elicited high levels of apoptosis (Figure 6C). However,with 100 PFU/cell of T3SA1 . Although infection of T3SA2
is substantially inhibited in HeLa cells incubated with incubation of cells with mAb J10.4 abolished the capac-
ity of T3SA1 to induce this response. Importantly, treat-mAb J10.4 (Figure 2B), growth of T3SA1 was only mini-
mally reduced (less than 2-fold at 48 hr) by hJAM block- ment of HeLa cells with mAb J10.4 had no effect on
the capacity of TNF-a to activate NF-kB and induceade (Figure 6A). Consistent with this finding, we also
observed z50% fewer reovirus-antigen-positive cells apoptosis, indicating that neither the NF-kB signaling
machinery nor the apoptotic response is inhibited byfollowing hJAM blockade and adsorption with T3SA1 at
an MOI of 1 PFU/cell (data not shown). These results anti-hJAM mAb J10.4 (Figures 6B and 6C). These results
demonstrate that while SA can mediate entry of SA-suggest that cell-surface SA can serve as a functional
receptor when hJAM is absent or inaccessible. binding reovirus strains, reovirus-induced NF-kB acti-
vation and resultant cell death require virus-inducedSince T3SA1 can infect HeLa cells via an hJAM-inde-
pendent pathway, it was possible to determine whether signaling events mediated by the interaction of s1
with JAM.s1–hJAM interactions modulate the efficiency of reovi-
rus-induced NF-kB activation. We found that T3SA1 in-
duced strong activation of NF-kB in untreated cells, but Discussion
this activation was abolished in cells treated with anti-
hJAM mAb J10.4 (Figure 6B). Since NF-kB activation is Results presented in this report demonstrate that JAM
satisfies all requisite criteria of a functional reovirus re-required for induction of apoptosis in reovirus-infected
Cell
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Figure 6. Anti-hJAM mAbs Inhibit NF-kB Ac-
tivation and Apoptosis Induction by Reovirus
T3SA1
(A) Effect of anti-hJAM mAb J10.4 on growth
of T3SA1 in HeLa cells. HeLa cells were incu-
bated with PBS or 5 mg/ml mAb J10.4 prior
to adsorption with T3SA1 at an MOI of 100
PFU/cell. Shown are mean viral titers for three
experiments. Error bars indicate standard de-
viations.
(B) Effect of anti-hJAM mAb J10.4 on NF-
kB activation induced by T3SA1 and TNF-a.
HeLa cells were incubated with PBS or 5 mg/
ml mAb J10.4 prior to adsorption with T3SA1
(100 PFU/cell) or treatment with TNF-a (20
ng/ml). Mock-infected cells are shown as a
control. After incubation for either 1 (TNF-a)
or 10 (T3SA1 ) hr, NF-kB complexes in nuclear
extracts were detected by EMSA.
(C) Effect of anti-hJAM mAb J10.4 on apopto-
sis induced by T3SA1 and TNF-a. HeLa cells
were incubated with PBS or 5 mg/ml mAb
J10.4 prior to adsorption with T3SA1 (100 PFU/
cell) or treatment with TNF-a (20 ng/ml). Mock-infected cells are shown as a control. After incubation for either 24 (TNF-a) or 48 (T3SA1 ) hr,
cells were stained with acridine orange. Shown is the mean percentage of cells undergoing apoptosis for three experiments. Error bars indicate
standard deviations.
ceptor. First, transfection of COS-7 cells with hJAM con- 1998; Liu et al., 2000). Reovirus gains access to the
basolateral surface of intestinal cells by transport throughfers binding of reovirus T3SA2. Second, blockade of
hJAM on the surface of NT2 cells, HeLa cells, or Caco-2 microfold cells (Wolf et al., 1981), which would allow
virus exposure to the area of highest JAM expression.cells abolishes T3SA2 binding and growth. Third, bind-
ing of prototype reovirus strains T1L and T3D to NT2 It is also possible that transient disruptions of the TJ
barrier, such as those that occur during migration ofcells is blocked by hJAM-specific mAbs. Fourth, trans-
fection of murine and avian cells with hJAM rescues immune and inflammatory cells, permit reovirus access
to JAM from the intestinal lumen. Such micro-disrup-reovirus infection in a serotype-independent manner.
Finally, and most conclusively, the biological effects of tions of TJ integrity facilitate infection by other patho-
gens, including Yersinia (McCormick et al., 1997) andhJAM on reovirus infection correlate with a direct, SA-
independent, high-affinity interaction between hJAM Salmonella (Jensen et al., 1998).
Since the discovery that differences in the tropism ofand the head domain of reovirus attachment protein s1.
JAM is a type I transmembrane protein with two extra- T1 and T3 reovirus for specific cells in the CNS segregate
with the s1-encoding S1 gene, it has been hypothesizedcellular Ig domains and a short cytoplasmic tail (Martin-
Padura et al., 1998; Liu et al., 2000). JAM is an important that T1 and T3 strains bind to distinct receptors ex-
pressed on ependymal cells and neurons, respectivelycomponent of TJs between endothelial and epithelial
cells, and it may function to organize TJ formation by (Weiner et al., 1980; Sharpe and Fields, 1985). However,
JAM confers infection by both T1 and T3 reovirus strains,interaction with other TJ proteins and the cytoskeleton
(Bazzoni et al., 2000; Ebnet et al., 2000). JAM also may suggesting that the interaction between JAM and the s1
head domain is not the critical determinant of serotype-influence the migration of leukocytes across endothelial
and epithelial barriers during the course of an inflamma- dependent differences in reovirus CNS tropism. Instead,
we think it possible that differences in the cell-surfacetory response (Del Maschio et al., 1999; Lechner et al.,
2000). JAM is highly conserved among mammals, with carbohydrates bound by T1 and T3 s1 proteins influence
viral tropism in the murine nervous system. Accordingly,human, murine, bovine, and rat JAM displaying z70%
amino acid identity (Martin-Padura et al., 1998; Liu et neural polysialic acid (Rutishauser and Landmesser,
1996) may permit infection by T3 strains, as was ob-al., 2000). Given the broad host range of mammalian
reovirus (Tyler and Fields, 1996), it is not surprising that served for T3SA1 infection of HeLa cells. Since T1
strains do not bind SA (Chappell et al., 2000), thesea reovirus receptor would display a high degree of se-
quence conservation. strains would be incapable of utilizing this pathway and
might even be repelled by the negatively-charged SAJAM is expressed on many cell types that are known
targets for reovirus infection in vivo, including intestinal moieties on the neural surface. Alternatively, it is possi-
ble that proteins with homology to JAM display sero-epithelium, bile duct epithelium, lung epithelium, leuko-
cytes, and CNS endothelial cells (Martin-Padura et al., type-specific interactions with s1.
T3 reovirus infects neurons and causes encephalitis1998; Williams et al., 1999; Liu et al., 2000). These obser-
vations are consistent with the extensive and overlap- in neonatal mice, but mice rapidly become resistant to
reovirus disease during the first few weeks of life (Tar-ping tissue distribution of T1 and T3 reovirus infections
in mice, particularly within the intestine (Tyler and Fields, dieu et al., 1983). As embryonic neuronal differentiation
progresses, the neuroepithelium down-regulates inte-1996). Cell-surface JAM is localized to the subapical
surface of polarized epithelial TJs (Martin-Padura et al., gral TJ proteins and loses the capacity to form TJs
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(Aaku-Saraste et al., 1996). JAM is not highly expressed
on adult mouse neurons (Martin-Padura et al., 1998);
however, its expression in the developing murine ner-
vous system has not been rigorously examined. It is
possible that JAM is expressed at birth and then de-
clines as neonatal CNS remodeling is completed,
thereby providing a mechanistic explanation for the age-
restriction of reovirus encephalitis.
The capacity of reovirus to interact with the TJ via JAM
may have important consequences for the pathology of
reovirus infection. Regulation of the TJ is critical for
maintenance of epithelial and endothelial barriers (Baz-
zoni et al., 1999). Anti-hJAM mAbs prevent the reorgani-
zation of disrupted TJs in cultured intestinal epithelial
Figure 7. Models of Reovirus–JAM Interactions at the Cell Surfacecells (Liu et al., 2000) and promote TJ breakdown of
(A) Non-SA-binding reovirus strains like T3SA2 bind JAM as a recep-the endothelium lining CNS blood vessels, resulting in
tor. Binding of these strains to JAM mediates virus internalizationenhanced disease in response to bacterial or viral infec-
but does not induce signals leading to activation of NF-kB.
tions (Lechner et al., 2000). If reovirus–JAM interactions (B) SA-binding reovirus strains like T3SA1 bind both JAM and SA.
lead to a similar destabilization of TJs in CNS endothe- The membrane-proximal Ig domain of hJAM contains two N-linked
glycosylation sites (Liu et al., 2000), one of which is schematicallylium, this might promote breakdown of the blood-brain
indicated. The dual ligation of JAM and JAM-bound SA is proposedbarrier, permitting cerebral edema and neural inflamma-
to induce JAM cross-linking or conformational alterations leadingtion, conditions evident in reovirus encephalitis (Tyler
to initiation of signals required for NF-kB activation and apoptosis.and Fields, 1996). In addition, reovirus-induced TJ dys-
(C) SA-binding reovirus strains also may activate intracellular signal-
regulation within the murine intestinal epithelium might ing pathways by the simultaneous crosslinking of JAM and other
promote diarrhea, thereby enhancing viral shedding and sialyllated cell-surface proteins.
transmission. A similar mechanism has been proposed
for the pathogenesis of diarrhea induced by rotavirus
(Obert et al., 2000). of TJ proteins that includes the Ras-interacting protein
Our finding that s1–JAM interactions are required for AF-6 (Bazzoni et al., 2000; Ebnet et al., 2000). Impor-
NF-kB activation and apoptosis underscores the impor- tantly, Ras-mediated pathways have been implicated in
tance of the attachment step in modulating the cellular activation of NF-kB (Anrather et al., 1999; Norris and
consequences of reovirus infection. Although T3SA1 is Baldwin, 1999; Romashkova and Makarov, 1999). Since
capable of efficient infection via SA-mediated attach- infection of newborn mice with T3 reovirus at a dose
ment, this route of infection seems to bypass the cellular that leads to lethal encephalitis also induces apoptosis
signaling events culminating in apoptosis, suggesting in the CNS (Oberhaus et al., 1997), our findings raise the
that viral replication is not sufficient to trigger this re-
possibility that reovirus–JAM interactions dictate strain-
sponse. Our findings demonstrate that reovirus binding
specific pathogenic phenotypes as a consequence of
to JAM is required for induction of the apoptotic re-
intracellular signaling in addition to determining viral
sponse; however, s1–JAM interactions are not the sole
tropism.determinant of virus-induced apoptosis. T3SA1 is much
It is interesting to speculate why reoviruses wouldmore efficient than T3SA2 at inducing NF-kB-dependent
utilize a receptor that triggers apoptotic death of theapoptosis in HeLa cells (J. L. C. et al., submitted), despite
infected cell. Although many viruses induce apoptosisthe fact that both strains bind JAM on this cell type. We
of host cells, only a select group encodes proteins thatpropose a model in which a virus-cell synapse formed
actively inhibit this process. For these viruses, it is likelyby multivalent interactions of s1 with both JAM and SA
that apoptosis must be blocked for a period sufficientsurpasses a critical cellular activation threshold required
to assemble viable progeny (Roulston et al., 1999). Reo-for NF-kB activation and apoptosis (Figure 7). This
virus replication requires z16 hr; however, the majoritymodel has similarities to mechanisms of lymphocyte
of reovirus-infected cells remain viable for up to 48 hractivation in which lymphocyte receptors must be en-
post-infection (Connolly et al., 2000). This interval wouldgaged by both antigen and accessory molecules to initi-
allow for multiple rounds of viral replication prior to cellate effector functions (Grakoui et al., 1999). JAM appears
death. Thus, there may be no selective advantage forto be the only receptor on some cell types for non-SA-
reovirus to inhibit the host cell apoptotic response. Inbinding reovirus strains. However, the binding of these
fact, there is increasing evidence to suggest that somestrains to JAM is not sufficient to trigger NF-kB activa-
viruses utilize apoptosis as a means to evade the hosttion (Figure 7A). In contrast, the simultaneous ligation
immune response by minimizing tissue inflammation andof JAM and SA moieties on JAM by SA-binding strains
permitting viral spread within apoptotic bodies (Teodoromay alter the conformation or oligomeric nature of JAM,
and Branton, 1997; O’Brien, 1998). Identification of JAMthereby triggering signaling events subsequent to virus
as a signaling molecule required for reovirus-inducedbinding (Figure 7B). Alternatively, SA-binding strains
apoptosis will permit dissection of the underlying mech-might bind JAM and SA residues on other cellular pro-
anisms and pathologic significance of apoptosis in re-teins, and the juxtaposition of JAM with these proteins
sponse to viral infection.may activate signaling cascades that culminate in apo-
Although a number of signaling molecules concen-ptotic cell death (Figure 7C). In support of the observed
coupling of JAM and NF-kB, JAM exists in a complex trate at the cytoplasmic face of the TJ, their roles in
Cell
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Assessment of Virus Growthtransducing signals from the environment to the nucleus
Cells (2–5 3 105) were incubated in PBS or PBS containing variousare unclear (Clarke et al., 2000; Hopkins et al., 2000).
concentrations of mAbs C5/D5, 7G2C9, or J10.4 at room tempera-We provide the first demonstration that JAM and the TJ
ture for 1 hr. Virus was adsorbed to antibody-treated cells at an
are involved in a discrete outside-in nuclear signaling MOI of 1 or 100 PFU/cell and incubated at room temperature for
pathway. NF-kB regulates the transcription of many in- 1 hr. Inocula were removed, cells were washed, and complete me-
dium was added. Cells were incubated at 378C for various intervals,flammatory cytokines involved in the activation and at-
and viral titers in lysates were determined by plaque assay.traction of immune effector cells (Pahl, 1999). The link-
age of JAM to NF-kB has important implications for the
Fluorescent-Focus Assay of Viral Infectionrole of the TJ in responding to pathogens and suggests
Virus was adsorbed to confluent monolayers as for growth experi-
that the TJ can serve as an environmental sensor capa- ments. Following incubation at 378C for 20 hr, cells were fixed with
ble of responding to viral infection by triggering apopto- 1 ml of methanol at 2208C for 30 min. Infected cells were identified
sis. The discovery of JAM as a reovirus receptor ex- by indirect immunofluorescence using rabbit anti-reovirus sera as
described (Barton et al., 2001).pands our knowledge of virus-receptor biology and
highlights a potential role for the TJ in regulating both
Virus Radioligand Binding Assaysinflammatory responses and cell death.
Purified virions (2–4 3 1013/ml in Dulbecco’s PBS [Gibco-BRL, Grand
Island, NY]) were iodinated and used for binding assays as described
(Barton et al., 2001). Iodinated virus was added to cells (1 3 106)Experimental Procedures
and incubated at room temperature for 3 hr. Cell-associated virus
was captured by vacuum filtration and quantitated by liquid scintilla-Cells, Viruses, and Antibodies
tion. For experiments assessing the effect of SLL or Fabs on virusL cells, MEL cells, and HeLa cells were maintained as described
attachment, iodinated virions were preincubated with each reagent(Barton et al., 2001). NTERA-2 (NT2) and Caco-2 cells were obtained
at 378C for 30 min. Antibodies against cell-surface proteins werefrom the American Type Culture Collection and maintained in mono-
preincubated with cells at 378C for 30 min prior to adsorption oflayer culture as for HeLa cells. CEF cells were derived from day 10
radiolabeled virus.fertilized chicken eggs and maintained as described (Brown et al.,
1999).
Cloning of mJAMReovirus strains T1L and T3D are laboratory stocks. Isogenic
mJAM was cloned by PCR amplification from Quickclone cDNAs1-point mutants T3/C44-SA2 and T3/C44-SA1, abbreviated in this
derived from poly-A mRNA of 7-day murine embryos (Clontech, Palomanuscript as T3SA2 and T3SA1 , respectively, were generated as
Alto, CA). cDNA (4 ng) was subjected to PCR with primers (0.2 mM)described (Barton et al., 2001). Viral titer was determined by plaque
specific for the reported mJAM sequence appended at the 59 andassay on L cells (Virgin et al., 1988). Purified virions were prepared
39 termini with XbaI and SpeI restriction sites, respectively (59-CCTand quantitated as described (Furlong et al., 1988). ISVPs were
ACTAGTGGATTGTAACTGTAATGGGCA-39 and 59-CCTTCTAGAGCgenerated as described (Baer and Dermody, 1997). Purified T3SA2
CGCAGCAGGTCACACCAGG-39) (Martin-Padura et al., 1998). PCR(1 3 1013/ml in carbonate-bicarbonate buffer [pH 9] [Sigma-Aldrich,
product was purified using DNAzol (Molecular Research Center,St. Louis, MO]) was fluoresceinated by incubation in 50 mg/ml FITC
Cincinnati, OH), treated with XbaI and SpeI, and ligated into the(Pierce, Rockford, IL) for 1 hr at room temperature.
XbaI and SpeI sites of alkaline phosphatase-treated pBK-CMV (Stra-Murine mAbs 9BG5 (Burstin et al., 1982) and 5C6 (Virgin et al.,
tagene). Fidelity of PCR amplification and cloning was confirmed1991) were purified from hybridoma supernatants (Cell Culture Cen-
by automated sequencing.ter, Minneapolis, MN), and Fabs of each were prepared using the
Immunopure Fab system (Pierce). Anti-hJAM murine mAbs J10.4,
Transient Transfection and Reovirus Infection of MEL Cells7G2C9, J3F.4, and 1H2A9 (all IgG1) (Williams et al., 1999; Liu et al.,
MEL cells (1 3 107) were transiently transfected with 40 mg each2000) and CD47-specific mAb C5/D5 (IgG1) (Parkos et al., 1996)
of pEGFP-N1 (Clontech) (transfection control), pBK-CMV (negativewere purified from ascites by protein A affinity. Rabbit hCAR-specific
control), hJAM 1-4-3, or hJAM 1-4-5 by electroporation. Transfectionantiserum was provided by Dr. Jeffrey Bergelson (University of
efficiency was z10%. After 48 hr incubation, 2 3 105 cells werePennsylvania).
adsorbed with T3SA2 , T3SA1 , T1L, or T3D at an MOI of 1 PFU/
cell in a total volume of 150 ml. Adsorptions were terminated after
incubation at room temperature for 1 hr by washing in PBS. CellsExpression Cloning of hJAM
were incubated at 378C in 1 ml of culture medium for various inter-COS-7 cells were transfected with an NT2 cDNA library (Stratagene,
vals, and viral titers in lysates were determined by plaque assay.La Jolla, CA) as described (Aruffo and Seed, 1987). After 48 hr
incubation, cells were detached from plates by incubation with 2 mM
EDTA/PBS at 378C. Detached cells (1 3 106) were resuspended in Transient Transfection and Reovirus Infection of CEF Cells
150 ml PBS containing 1 3 1011 FITC-conjugated T3SA2 particles Passage-five CEF cells (50%–75% confluence) were transfected
and incubated on ice for 1 hr. Cells were washed twice with PBS, with 0.4 mg of plasmid encoding hCAR (in pCDNA 3.1), hJAM, or
viable cells were analyzed by FACS, and the 0.5% most fluorescent mJAM using Lipofectamine Plus (Gibco-BRL). Transfected CEF cells
cells were collected using a FACStar Plus (Becton, Dickinson and were infected with virions or ISVPs of T3SA2 , T3SA1 , or T1L at an
Co., Franklin Lakes, NJ). Plasmid was rescued from sorted cells MOI of 10 PFU per cell and processed for fluorescent-focus assay.
(Hirt, 1967), amplified in bacteria, and used in three subsequent
rounds of FACS enrichment. Individual bacterial colonies obtained Generation and Purification of Fc-hJAM Fusion Protein
from the quaternary sort were grouped into pools of 50 colonies. The hJAM extracellular domain was amplified by PCR from 1 mg of
Plasmid prepared from pools was used to transfect COS-7 cells. hJAM clone 1-4-5 using hJAM-specific primers (0.2 mg) appended
Positive pools were defined as those conferring a greater than 2% with HindIII and BamHI restriction sites at the 59 and 39 termini,
increase in the number of maximally-fluorescent cells as compared respectively (59-TAGCAAGCTTCCTGATCGCGATG-39 and 59-TACG
to cells transfected with cDNA library. Positive pools were subdi- GGATCCATTCCGCTCCAC-39). PCR product and Fc-hCAR-pCDNA
vided into sub-pools of 5 colonies, and plasmid from sub-pools was 3.1 (Bergelson et al., 1997) were subjected to restriction digest with
tested for the capacity to confer enhanced FITC-T3SA2 binding to HindIII and BamHI, resulting in excision of hCAR-encoding se-
transfected COS-7 cells. Individual clones from positive sub-pools quences from the plasmid vector. Digestion products were purified
were similarly screened. This process yielded four clones that con- by agarose gel electrophoresis, and the hJAM PCR product was
ferred T3SA2 binding to all transfected COS-7 cells (1-4-3, 1-4-5, ligated into the digested Fc-pCDNA plasmid. Fidelity of PCR amplifi-
8-10-2, and 8-10-3). Automated sequencing revealed that each cation and cloning was confirmed by automated sequencing.
The Fc-hJAM and Fc-hCAR plasmid constructs were amplified inclone encoded hJAM (Liu et al., 2000).
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